Pharmacodynamic Properties of CJ-12420 on Evening Dosing
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT03043521
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT03011996
- Locations
- 🇰🇷
Inje University Busan Baik Hospital, Busan, Korea, Republic of
To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 16
- Registration Number
- NCT03009760
Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT03009474
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-12-30
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 302
- Registration Number
- NCT03006874
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
A Study to Compare the Pharmacokinetic Characteristics of CJ-12420
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-12-16
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT02995239
- Locations
- 🇰🇷
Chonbuk National University Hospital, Chonju, Korea, Republic of
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 306
- Registration Number
- NCT02761512
- Locations
- 🇰🇷
Kyung Hee University Medical Center, Seoul, Korea, Republic of
🇰🇷Catholic Univ. Seoul St. Mary Hospita, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2018-04-04
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 324
- Registration Number
- NCT02556021
- Locations
- 🇰🇷
Yeouido St.Mary's Hospital, Seoul, Korea, Republic of
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 280
- Registration Number
- NCT02456935
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2016-12-30
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT02378441
© Copyright 2024. All Rights Reserved by MedPath